We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Making of a Myth

L. Eugene Arnold, MD; Walter Knopp, MD
JAMA. 1973;223(11):1273-1274. doi:10.1001/jama.1973.03220110051016.
Text Size: A A A
Published online


In 1967, Millichap and Fowler1 published a valuable review of the available literature studying drug treatment of hyperkinetic children. They broke down the adequately controlled studies into several tables. They further digested the information by combining and averaging the results from many studies to get the average percentages improved with each drug. Using these percentages, they listed the drugs in the order of apparent efficacy as "the closest approximation possible with the evidence available." At the head of the list, with 83% improvement, was methylphenidate hydrochloride (Ritalin). Next came dextroamphetamine sulfate (Dexedrine) with 69% improvement.

The casual reader might jump to the conclusion that methylphenidate's superiority to dextroamphetamine had been established. However, the rest of the article had already made it clear that these two percentages were based on separate studies of different drugs by different investigators on different population samples with different dosages and different criteria of improvement.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.